FI893643A - Farmaceutiska kompositioner. - Google Patents

Farmaceutiska kompositioner. Download PDF

Info

Publication number: FI893643A
Authority: FI; Finland
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 1988-08-18

Application number

FI893643A

Other languages

English (en)

Other versions

FI893643A0 (fi

Inventor

John J Nestor

Brian H Vickery

Original Assignee

Syntex Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-08-18

Filing date

1989-08-01

Publication date

1990-02-19

1989-08-01 Application filed by Syntex Inc filed Critical Syntex Inc

1989-08-01 Publication of FI893643A0 publication Critical patent/FI893643A0/fi

1990-02-19 Publication of FI893643A publication Critical patent/FI893643A/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

FI893643A 1988-08-18 1989-08-01 Farmaceutiska kompositioner. FI893643A (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US23369088A	1988-08-18	1988-08-18

Publications (2)

Publication Number	Publication Date
FI893643A0 FI893643A0 (fi)	1989-08-01
FI893643A true FI893643A (fi)	1990-02-19

Family

ID=22878305

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI893643A FI893643A (fi)	1988-08-18	1989-08-01	Farmaceutiska kompositioner.

Country Status (11)

Country	Link
EP (1)	EP0363589A3 (fi)
JP (1)	JPH0273100A (fi)
KR (1)	KR900003205A (fi)
AU (1)	AU3926589A (fi)
DK (1)	DK375789A (fi)
FI (1)	FI893643A (fi)
HU (1)	HUT50487A (fi)
IL (1)	IL91166A0 (fi)
NO (1)	NO893088L (fi)
PT (1)	PT91384A (fi)
ZA (1)	ZA895838B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5985240A (en) *	1989-08-09	1999-11-16	Rhomed Incorporated	Peptide radiopharmaceutical applications
DE69110519T2 (de) *	1990-04-06	1995-11-30	Univ Tulane	Somatostatinanaloge.
DK0542934T3 (da) *	1991-02-08	1999-11-22	Biomeasure Inc	Anvendelse af somatostatinanaloger til behandling af melanomer
US5504069A (en) *	1993-02-11	1996-04-02	Biomeasure, Inc.	Inhibition of trauma-induced tumor growth
HU224350B1 (hu)	1993-08-09	2005-08-29	Société de Conseils de Recherches et d'ApplicationScientifiques, S.A.S. Á	Gyógyhatású peptidszármazékok
US5597894A (en) *	1995-06-05	1997-01-28	The Louisiana State University Medical Center Foundation	Multi-tyrosinated somatostatin analogs
IL120443A (en) *	1996-03-18	2000-07-16	Sankyo Co	Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
ATE245998T1 (de)	1997-05-13	2003-08-15	Sod Conseils Rech Applic	Somatostatin agoniste zur reduzierung von körpergewicht
WO1998051330A1 (en)	1997-05-13	1998-11-19	Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.)	Method and compositions for treating hyperlipidemia and other conditions
DK0980253T3 (da) *	1997-05-13	2004-07-05	Sod Conseils Rech Applic	Somatostatin og somatostatinagonister til behandling af insulininsensitivitet og syndrom X
US6004928A (en) *	1997-05-13	1999-12-21	Biomeasure, Incorporated	Method of treating hyperlipidemia
US5968903A (en) *	1998-05-07	1999-10-19	Biomeasure, Incorporated	Inhibition of H. pylori proliferation
CZ305160B6 (cs)	2001-06-08	2015-05-27	Ipsen Pharma S.A.S.	Chimérické somatostatin-dopaminové analogy
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
CN101791409A (zh)	2003-04-22	2010-08-04	研究及应用科学协会股份有限公司	肽载体
BRPI0915142A8 (pt)	2008-06-12	2018-01-02	Syntaxin Ltd	Polipeptídeos, ácido nucleico e usos dos mesmos
EP3590956A1 (en)	2008-06-12	2020-01-08	Ipsen Bioinnovation Limited	Suppression of neuroendocrine diseases
GB0820970D0 (en)	2008-11-17	2008-12-24	Syntaxin Ltd	Suppression of cancer
US20160129089A1 (en)	2013-06-13	2016-05-12	Antisense Therapeutics Ltd	Combination therapy
CN108174843B (zh) *	2018-01-24	2018-11-13	广州市进德生物科技有限公司	一种胰高血糖素保护剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4372884A (en) *	1975-08-06	1983-02-08	The Salk Institute For Biological Studies	Pharmaceutically active peptides
CH621770A5 (en) *	1976-02-23	1981-02-27	Sandoz Ag	Process for the preparation of novel peptide compounds
IL60214A0 (en) *	1979-06-11	1980-09-16	Lilly Co Eli	Peptides related to somatostatin
CY1327A (en) *	1979-11-27	1986-06-27	Sandoz Ag	Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use
GR862206B (en) *	1985-09-12	1986-12-31	Univ Tulane	Therapeutic somatostatin analogs

1989
- 1989-07-31 NO NO89893088A patent/NO893088L/no unknown
- 1989-07-31 ZA ZA895838A patent/ZA895838B/xx unknown
- 1989-07-31 DK DK375789A patent/DK375789A/da not_active Application Discontinuation
- 1989-08-01 IL IL91166A patent/IL91166A0/xx unknown
- 1989-08-01 FI FI893643A patent/FI893643A/fi not_active Application Discontinuation
- 1989-08-03 AU AU39265/89A patent/AU3926589A/en not_active Abandoned
- 1989-08-03 HU HU893947A patent/HUT50487A/hu unknown
- 1989-08-03 JP JP1203699A patent/JPH0273100A/ja active Pending
- 1989-08-03 EP EP89114365A patent/EP0363589A3/en not_active Withdrawn
- 1989-08-04 PT PT91384A patent/PT91384A/pt unknown
- 1989-08-04 KR KR1019890011225A patent/KR900003205A/ko not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA895838B (en)	1991-03-27
HUT50487A (en)	1990-02-28
DK375789A (da)	1990-02-19
EP0363589A3 (en)	1990-08-16
IL91166A0 (en)	1990-03-19
EP0363589A2 (en)	1990-04-18
NO893088L (no)	1990-02-19
DK375789D0 (da)	1989-07-31
KR900003205A (ko)	1990-03-26
FI893643A0 (fi)	1989-08-01
JPH0273100A (ja)	1990-03-13
NO893088D0 (no)	1989-07-31
PT91384A (pt)	1990-03-08
AU3926589A (en)	1990-02-22

Publication	Publication Date	Title
FI901102A0 (fi)	1990-03-05	Farmaceutiska kompositioner.
FI922364A (fi)	1992-05-22	Farmaceutiska kompositioner.
DE68901417D1 (de)	1992-06-11	Pharmazeutische zusammensetzung.
DE68907659D1 (de)	1993-08-26	Warmhaertende organosiloxanzusammensetzung.
FI895681A0 (fi)	1989-11-28	Farmaceutisk komposition foer systemisk transdermal tillfoersel.
DE3863963D1 (de)	1991-09-05	Pharmazeutische zusammensetzungen.
ATE98480T1 (de)	1994-01-15	Arzneimittelformulierungen.
DE3868986D1 (de)	1992-04-16	Pharmazeutische zusammensetzungen.
DE3485408D1 (de)	1992-02-13	Pharmazeutische zusammensetzung.
IT8920486A0 (it)	1989-05-12	Composizioni farmaceutiche.
FI893643A (fi)	1990-02-19	Farmaceutiska kompositioner.
IT8820386A0 (it)	1988-04-29	Composizioni farmaceutiche orosolubili contenti acetilcisteina.
NO882653D0 (no)	1988-06-15	Doseringsform.
DE68916395D1 (de)	1994-07-28	Zusammensetzung.
FI872733A0 (fi)	1987-06-18	Farmaceutiska kompositioner.
DE68907177D1 (de)	1993-07-22	Dosierungsform.
FI872313A0 (fi)	1987-05-25	Farmaceutiska kompositioner.
FI883673A0 (fi)	1988-08-05	Farmaceutiska kompositioner.
IT1213453B (it)	1989-12-20	Composizione farmaceutica.
DE68906193D1 (de)	1993-06-03	Hypersphyxia verursachende zusammensetzung.
FI905236A0 (fi)	1990-10-24	Deoxiribonukleosider innehaollande farmaceutiska konsistenser foer laekning av saor.
FI874414A (fi)	1988-04-10	Kontrollerat frigoerande farmaceutiska kompositioner.
DE68903729D1 (de)	1993-01-14	Tertiaere thiolaethoxylat-zusammensetzung.
DE3866789D1 (de)	1992-01-23	Pharmazeutische zusammensetzungen.
DE68907609D1 (de)	1993-08-19	Arzneimittelzusammensetzung.

Legal Events

Date	Code	Title	Description
2004-08-31	FD	Application lapsed	Owner name: SYNTEX (U.S.A.) INC.